Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Posted on by ScienceFather

Prof. Dr. Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Prof. Dr. Nurşen Sarı, GAZI UNIVERSITY, Turkey

Prof. Dr. Nurşen Sarı is a distinguished academic in Inorganic Chemistry with a focus on Polymeric Complexes, Bioinorganic Chemistry, and Transition Metals. She has authored 63 articles in SCI/SCI-Expanded journals and over 200 conference proceedings. Prof. Sarı has supervised 17 graduate theses and taught various courses such as Supramolecular Chemistry and Metallurgical Chemistry at Gazi University, where she served as Vice Chair and Erasmus Coordinator. She is passionate about chemistry, seeing it as the key to understanding life. 🌍🔬📚

Publication Profile

Orcid

Google Scholar

Academic and Administrative Leadership

Prof. Dr. Nurşen Sarı has held key academic and administrative roles at Gazi University. She served as a Board Member at the Institute of Science and Technology (2018-2021) and as Vice Chair of the Department of Chemistry (2013-2020). She led the Chemistry Community as Academic Leader (2016-2019) and coordinated the Erasmus Program for the department (2013-2016). Additionally, Prof. Sarı was the Farabi Department Coordinator (2013-2016). Her leadership has significantly shaped the university’s academic direction. 📚🌍🎓👩‍🏫

 

Research Areas

Prof. Dr. Nurşen Sarı’s research spans diverse areas of Inorganic Chemistry and Bioinorganic Chemistry, focusing on Polymeric Complexes, Transition Metals, and Inorganic Polymers. Her work explores the structure and behavior of Inorganic Ring Compounds, Coordination Chemistry, and the mechanisms and kinetics of inorganic reactions. Prof. Sarı’s research contributes significantly to the understanding of the interactions between metals and organic ligands, which has applications in various scientific fields. Her passion for Natural Sciences drives her to uncover new insights into the molecular world. 🌐🔬🧪🧬

 

Research Focus

Prof. Dr. Nurşen Sarı’s research focuses on several key areas within Inorganic and Bioinorganic Chemistry. Her work includes the synthesis and biological activities of polymeric complexes, Schiff bases, and their transition metal complexes, exploring their antimicrobial and antifungal properties. She also investigates coordination chemistry, inorganic polymers, and reaction mechanisms. Her studies contribute to the development of new materials with applications in biosensors, antimicrobial agents, and medical diagnostics. These endeavors have led to significant publications in prestigious journals. 🧪🔬⚗️🌍🧫

 

Publication Top Notes  

🔍 Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid (glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese (III) complexes
Cited by: 195
Year: 2004

🔍 ANTIBACTERIAL ACTIVITES OF SOME NEW AMINO ACID-SCHI BASES
Cited by: 160
Year: 2003

🔍 Synthesis and biological activity of new cycloalkylthiophene-Schiff bases and their Cr (III) and Zn (II) complexes
Cited by: 57
Year: 2010

🔍 Synthesis, potentiometric and antimicrobial activity studies on 2-pyridinilidene-DL-amino acids and their complexes
Cited by: 55
Year: 2003

🔍 Structural, electrochemical and optical properties of hydrothermally synthesized transition metal oxide (Co3O4, NiO, CuO) nanoflowers
Cited by: 46
Year: 2020

🔍 Synthesis of Some Polymer‐Metal Complexes and Elucidation of their Structures
Cited by: 46
Year: 2006

🔍 Spectroscopic characterization of novel d-amino acid-Schiff bases and their Cr(III) and Ni(II) complexes as antimicrobial agents
Cited by: 37
Year: 2013

🔍 Preparation of carbon paste electrodes including poly (styrene) attached glycine–Pt (IV) for amperometric detection of glucose
Cited by: 34
Year: 2014

🔍 Nanospheres caped Pt (II) and Pt (IV): synthesis and evaluation as antimicrobial and Antifungal Agent
Cited by: 31
Year: 2017

🔍 Ni (II)-tetrahedral complexes: Characterization, antimicrobial properties, theoretical studies and a new family of charge-transfer transitions
Cited by: 31
Year: 2013

🔍 Some novel amino acid-schiff bases and their complexes synthesis, characterization, solid state conductivity behaviors and potentiometric studies
Cited by: 29
Year: 2004

🔍 Synthesis, antimicrobial and antimutagenic effects of novel polymeric-Schiff bases including indol
Cited by: 27
Year: 2019

🔍 Polystyrene attached Pt (IV)–azomethine, synthesis and immobilization of glucose oxidase enzyme
Cited by: 27
Year: 2012

🔍 Synthesis, potentiometric and antimicrobial activity studies on DL-amino acids-Schiff bases and their complexes
Cited by: 27

 

Jesus Alonso Gandara Mireles | Pharmacology, Toxicology and Pharmaceutical Science | Young Scientist Award

Posted on by ScienceFather

Dr. Jesus Alonso Gandara Mireles | Pharmacology, Toxicology and Pharmaceutical Science | Young Scientist Award

Researcher,  National Polytechnic Institute,  Mexico.

Jesús Alonso Gándara Mireles is an exemplary candidate for the Research for Young Scientist Award, with extensive qualifications in biotechnology. He holds a Bachelor’s degree and multiple master’s degrees, culminating in a PhD focused on pharmacokinetics and pharmacogenetics in oncology. Currently completing a Postdoctoral Fellowship at the National Polytechnic Institute, Jesús conducts research aimed at optimizing chemotherapy for pediatric cancer patients. His experience includes prestigious internships at the University at Buffalo and the University of San Diego, enhancing his expertise. As a member of key professional organizations, he demonstrates a strong commitment to advancing personalized medicine and improving patient outcomes.

Publication Profile :

Scopus

Educational Background :

Jesús’s educational achievements are impressive and relevant to his research interests. He holds a Bachelor’s degree in Biotechnology with a biomedical focus, followed by a Master’s in Molecular and Cellular Biology, a Master’s in Human Genetics, and a Master’s in Clinical Pharmacokinetics. His PhD, centered on pharmacokinetics and pharmacogenetics in oncology, underscores his specialized knowledge in this vital area of research. This rigorous academic training has equipped him with the necessary skills to tackle complex scientific problems in the field of cancer treatment.

Professional Experiences :

Jesús Alonso Gándara Mireles has accumulated extensive professional experience in biotechnology and clinical research, particularly in the fields of pharmacogenetics and pharmacokinetics. Currently, he is completing a Postdoctoral Fellowship at the National Polytechnic Institute (IPN), focusing on the pharmacokinetics of oncology agents in pediatric patients. His previous internships include significant roles in Clinical Pharmacokinetics at the National Institute of Pediatrics and Pediatric Cancer Pharmacology at the University at Buffalo. He also engaged in research on Pediatric Cancer Genetics at the University of San Diego. His work aims to optimize treatment strategies and reduce chemotherapy-induced adverse effects in childhood cancer.

Research Contribution  :

Throughout his career, Jesús has gained valuable research experience through multiple internships. His exposure to pharmacokinetics and pharmacogenetics at prestigious institutions, including the University at Buffalo and the University of San Diego, highlights his capability to engage with leading experts and contribute to groundbreaking research. His current work focuses on optimizing chemotherapy for children by reducing adverse effects through personalized medicine, emphasizing his innovative approach to healthcare challenges.

Awards And Achievements :

Jesús Alonso Gándara Mireles has earned notable recogn ition throughout his academic and research career. As a member of the National System of Researchers (CONACYT) at Level 1, he has demonstrated his commitment to advancing scientific knowledge. His research contributions have been acknowledged through prestigious internships, including those at the National Institute of Pediatrics and the University at Buffalo. Additionally, Jesús is an active member of the International Society of Pediatric Oncology (SIOP) and the Latin American Society of Pharmacogenomics and Personalized Medicine (SOLFAGEM). These affiliations reflect his dedication to pediatric oncology and personalized medicine, underscoring his impactful contributions to the field.

Conclusion : 

Jesús Alonso Gándara Mireles is an outstanding candidate for the Research for Young Scientist Award. His impressive educational background, significant research experience, and active participation in professional networks make him a valuable contributor to the field of biotechnology and pediatric oncology. His work has the potential to greatly improve treatment outcomes for children with cancer, demonstrating his commitment to advancing scientific knowledge and enhancing patient care. Therefore, I strongly endorse his nomination for this esteemed award.

Publication Top Notes :

  • “Influence of Age, Gender and Body Mass Index on Intravenous Pharmacokinetics of Buprenorphine in Children Undergoing Orthopedic Surgery” (2024) – 🏥
  • “Population pharmacokinetics and pharmacodynamics of L-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with leukemia under treatment” (2024) – 🧬
  • “Nutritional Status as a Risk Factor for Doxorubicin Cardiotoxicity in Mexican Children with Acute Lymphoblastic Leukemia” (2024) – 🍽️
  • “Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia” (2023) – ⚗️ Cited by: 3
  • “Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia” (2021) – 🧬 Cited by: 8
  • “Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population” (2021) – 🔬 Cited by: 3

Nasim Ahmed | Drug Discovery Award | Excellence in Research

Posted on by ScienceFather

Mr. Nasim Ahmed | Drug Discovery Award | Excellence in Research

Mr. Nasim Ahmed,Department of Pharmacy, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, 1902 Bangladesh

Nasim Ahmed is a diligent pharmacist and researcher from Bangladesh, specializing in medicinal chemistry and computational drug development. With a Master’s degree in Pharmacy from Mawlana Bhashani Science and Technology University, Nasim has delved into diverse projects, from synthesizing silver nanoparticles to investigating natural compounds’ potential against diseases like diabetes and cancer. His extensive research contributions are showcased through numerous publications and ongoing projects. Nasim’s leadership extends beyond academia, founding clubs and contributing to community welfare initiatives. Armed with a TOEFL-iBT score of 90 and a rich skillset in wet-lab and dry-lab techniques, Nasim is a versatile professional poised to make significant contributions to the field of pharmaceutical sciences.

 

Publication Profile

Orcid

Education

 

Nasim Ahmed’s academic journey is marked by excellence and innovation. Graduating with a Master of Pharmacy (M. Pharm) from Mawlana Bhashani Science and Technology University, Bangladesh, he explored the multifaceted potential of green-synthesized silver nanoparticles combined with Zingiber Officinale Rhizome Extract, investigating antibacterial, antioxidant, cytotoxicity, and analgesic properties. His thesis also introduced novel inhibitors targeting the NfSAHH receptor of Naegleria fowleri, offering insights into combating amoebic meningoencephalitis through computational drug development. With a CGPA of 3.21 for his Master’s and a Bachelor of Professional Pharmacy (B. Pharm) with a CGPA of 3.57, Nasim exemplifies academic prowess and dedication to advancing pharmaceutical science. 🎓

 

Work Experience

Nasim Ahmed has showcased his expertise and commitment to advancing pharmaceutical research. As a Collaborative Research Assistant at Jashore University of Science and Technology, he delves into computational drug discovery under the guidance of Professor Dr. Md. Nazmul Hasan, contributing to scientific publications. At Mawlana Bhashani Science and Technology University, Nasim serves as a Research Assistant, proficiently handling wet lab and computational assays while mentoring undergraduates. His role at BioSol Centre involves remote computational lab work, where he contributes to cutting-edge research in drug development. Nasim’s dedication and multidisciplinary skills are pivotal in driving forward innovative pharmaceutical solutions. 💼🔬

Teaching Experience :

Nasim Ahmed’s passion for education extends beyond research, as evidenced by his teaching experiences. From April to August 2023, he imparted Computational Drug Development Training to undergraduate students, sharing his expertise and insights in this specialized field. Prior to this, from 2015 to 2019, Nasim dedicated himself to educating higher secondary school students in Biology and Chemistry, nurturing young minds and laying strong foundations in science. His commitment to both higher education and secondary education underscores his desire to inspire and empower future generations in the realm of pharmaceutical sciences. 🎓📚

 

Honors

 

Nasim Ahmed’s contributions and leadership roles in various conferences and organizations underscore his commitment to both academic excellence and community welfare. He delivered an oral presentation on antioxidant activity at the 2nd International Conference on Advancement of Life Sciences in 2021, showcasing his research prowess. Additionally, his poster presentation on genetic transformation at the National Biotechnology Fair in 2018 demonstrated his innovative approach to addressing antibiotic resistance. As a founder of the Pharmacy Career and Higher Study Club, member of the Rotaract Club, and secretary-general of the Central Dramatic Club, Nasim actively fosters community engagement and personal development. His efforts in fundraising for disaster relief and promoting health awareness initiatives reflect his dedication to social responsibility. 🏆🌱

Research Focus

Nasim Ahmed’s research focus encompasses the exploration of bioactive compounds derived from natural sources, particularly plants, for their potential therapeutic applications. He delves into the molecular mechanisms underlying the pharmacological activities of these compounds, with a keen interest in anti-cancer and anti-viral properties. Through comprehensive reviews and computational drug development approaches, Nasim aims to unravel the therapeutic potential of dietary phytochemicals against diseases like breast cancer and dengue. His dedication to understanding the intricate interactions between bioactive molecules and disease pathways reflects his commitment to advancing medicinal science for improved healthcare outcomes. 🌿🔬

Publication Top Notes

 

Amazon Plant‐Derived Compounds Suppressing Dengue NS5 Protein: Insights from Computational Drug Development and Network Pharmacology Approach

Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review

Exploring the anti‐cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review